FDA NDC Directory · JSON-LD · Markdown

Loxapine

NDC 0591-0372 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerActavis Pharma, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA072062
Dosage form / routeCAPSULE · ORAL
Active ingredientsLOXAPINE SUCCINATE (50 mg/1)
Marketing started19880615
Package count1

External sources

Source: openFDA. Public-domain (CC0).